S&P 500   5,146.29 (-1.01%)
DOW   38,109.02 (-0.91%)
QQQ   439.36 (-1.35%)
AAPL   176.09 (+0.60%)
MSFT   421.40 (-1.53%)
META   513.96 (-1.76%)
GOOGL   157.77 (-1.03%)
AMZN   186.56 (-1.32%)
TSLA   171.84 (-1.58%)
NVDA   885.43 (-2.29%)
AMD   163.63 (-4.03%)
NIO   4.13 (-7.40%)
BABA   72.44 (-3.22%)
T   16.44 (+0.12%)
F   12.73 (-2.38%)
MU   123.37 (-3.25%)
GE   154.44 (-1.88%)
CGC   8.05 (-1.23%)
DIS   114.19 (-2.53%)
AMC   2.70 (-3.57%)
PFE   26.14 (-0.76%)
PYPL   65.40 (-0.61%)
XOM   123.30 (+1.24%)
S&P 500   5,146.29 (-1.01%)
DOW   38,109.02 (-0.91%)
QQQ   439.36 (-1.35%)
AAPL   176.09 (+0.60%)
MSFT   421.40 (-1.53%)
META   513.96 (-1.76%)
GOOGL   157.77 (-1.03%)
AMZN   186.56 (-1.32%)
TSLA   171.84 (-1.58%)
NVDA   885.43 (-2.29%)
AMD   163.63 (-4.03%)
NIO   4.13 (-7.40%)
BABA   72.44 (-3.22%)
T   16.44 (+0.12%)
F   12.73 (-2.38%)
MU   123.37 (-3.25%)
GE   154.44 (-1.88%)
CGC   8.05 (-1.23%)
DIS   114.19 (-2.53%)
AMC   2.70 (-3.57%)
PFE   26.14 (-0.76%)
PYPL   65.40 (-0.61%)
XOM   123.30 (+1.24%)
S&P 500   5,146.29 (-1.01%)
DOW   38,109.02 (-0.91%)
QQQ   439.36 (-1.35%)
AAPL   176.09 (+0.60%)
MSFT   421.40 (-1.53%)
META   513.96 (-1.76%)
GOOGL   157.77 (-1.03%)
AMZN   186.56 (-1.32%)
TSLA   171.84 (-1.58%)
NVDA   885.43 (-2.29%)
AMD   163.63 (-4.03%)
NIO   4.13 (-7.40%)
BABA   72.44 (-3.22%)
T   16.44 (+0.12%)
F   12.73 (-2.38%)
MU   123.37 (-3.25%)
GE   154.44 (-1.88%)
CGC   8.05 (-1.23%)
DIS   114.19 (-2.53%)
AMC   2.70 (-3.57%)
PFE   26.14 (-0.76%)
PYPL   65.40 (-0.61%)
XOM   123.30 (+1.24%)
S&P 500   5,146.29 (-1.01%)
DOW   38,109.02 (-0.91%)
QQQ   439.36 (-1.35%)
AAPL   176.09 (+0.60%)
MSFT   421.40 (-1.53%)
META   513.96 (-1.76%)
GOOGL   157.77 (-1.03%)
AMZN   186.56 (-1.32%)
TSLA   171.84 (-1.58%)
NVDA   885.43 (-2.29%)
AMD   163.63 (-4.03%)
NIO   4.13 (-7.40%)
BABA   72.44 (-3.22%)
T   16.44 (+0.12%)
F   12.73 (-2.38%)
MU   123.37 (-3.25%)
GE   154.44 (-1.88%)
CGC   8.05 (-1.23%)
DIS   114.19 (-2.53%)
AMC   2.70 (-3.57%)
PFE   26.14 (-0.76%)
PYPL   65.40 (-0.61%)
XOM   123.30 (+1.24%)

Nemaura Medical (NMRD) News Today

$0.08
0.00 (-3.41%)
(As of 09:30 AM ET)
SourceHeadline
benzinga.com logoNemaura Medical Stock (OTC:NMRD) Earnings Dates and Earning Calls
benzinga.com - February 23 at 2:40 AM
finance.yahoo.com logoMaxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET
finance.yahoo.com - January 22 at 4:53 PM
finanznachrichten.de logoNemaura Medical, Inc: Important Update on Listing Status and Strategic Direction
finanznachrichten.de - January 3 at 7:55 AM
finance.yahoo.com logoImportant Update on Listing Status and Strategic Direction
finance.yahoo.com - January 3 at 7:55 AM
markets.businessinsider.com logoBuy Rating Affirmed for Nemaura Medical on sugarBEAT Prospects and Market Expansion
markets.businessinsider.com - December 20 at 7:00 AM
finanznachrichten.de logoNemaura Medical, Inc: Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision
finanznachrichten.de - December 13 at 9:00 AM
finance.yahoo.com logoNemaura Medical Inc. Receives Positive Nasdaq Listing Decision
finance.yahoo.com - December 13 at 9:00 AM
msn.com logoNemaura Medical (NMRD) Price Target Increased by 54.55% to 8.67
msn.com - November 27 at 8:27 AM
finance.yahoo.com logoNemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
finance.yahoo.com - November 21 at 9:52 AM
msn.com logoNemaura (NMRD) to Expand in UK With Metabolic Health Program
msn.com - November 17 at 1:30 PM
finance.yahoo.com logoNemaura Medical First Half 2024 Earnings: US$0.13 loss per share (vs US$0.33 loss in 1H 2023)
finance.yahoo.com - November 16 at 8:00 AM
finanznachrichten.de logoNemaura Medical, Inc: Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update
finanznachrichten.de - November 15 at 5:30 PM
seekingalpha.com logoAcutus Medical Non-GAAP EPS of -$0.52, revenue of $5.2M
seekingalpha.com - November 14 at 3:18 PM
finanznachrichten.de logoNemaura Medical, Inc: Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs
finanznachrichten.de - November 14 at 3:18 PM
finance.yahoo.com logoNemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs
finance.yahoo.com - November 14 at 8:50 AM
finance.yahoo.com logoNemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update
finance.yahoo.com - November 13 at 6:19 PM
msn.com logoSeaStar Medical gets FDA breakthrough status for cytokine storm device
msn.com - October 18 at 1:32 PM
finance.yahoo.com logoNemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.
finance.yahoo.com - September 26 at 10:10 AM
finance.yahoo.com logoNemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference
finance.yahoo.com - September 18 at 9:38 AM
seekingalpha.com logoNemaura Medical says compliance regain with Nasdaq rules not expected
seekingalpha.com - September 16 at 5:57 PM
finanznachrichten.de logoNemaura Medical, Inc: Nemaura Medical Provides Update on Nasdaq Compliance Status and Process
finanznachrichten.de - September 14 at 12:50 PM
finance.yahoo.com logoNemaura Medical Provides Update on Nasdaq Compliance Status and Process
finance.yahoo.com - September 14 at 8:55 AM
benzinga.com logoTop Penny Stock Gainers Momentum Watchlist (ORHB, GSAC, NMRD, SASI)
benzinga.com - September 14 at 7:50 AM
finance.yahoo.com logoNemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program
finance.yahoo.com - September 13 at 9:53 AM
finance.yahoo.com logoNemaura Medical Announces Participation at HLTH 2023, Las Vegas
finance.yahoo.com - September 12 at 2:38 PM
finance.yahoo.com logoNemaura Medical Completes 100 Patient Study for sugarBEAT® 24-hour Wear and Reports Interim Results
finance.yahoo.com - September 11 at 9:50 AM
finance.yahoo.com logoNemaura Medical, Inc. (NMRD) Upgraded to Buy: What Does It Mean for the Stock?
finance.yahoo.com - August 23 at 6:59 PM
msn.com logoHC Wainwright & Co. Maintains Nemaura Medical (NMRD) Buy Recommendation
msn.com - August 21 at 11:27 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Nemaura Medical (NMRD), Kineta (KA) and Regeneron (REGN)
markets.businessinsider.com - August 21 at 7:22 AM
finance.yahoo.com logoNemaura Medical Announces SFDA Approval of sugarBEAT®
finance.yahoo.com - August 17 at 10:35 AM
finance.yahoo.com logoNemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update
finance.yahoo.com - August 14 at 9:26 AM
finance.yahoo.com logoNemaura Medical Secures $6.5m in Non-Dilutive Funding
finance.yahoo.com - August 11 at 7:47 PM
msn.com logoNemaura Medical (NMRD) Price Target Decreased by 8.70% to 7.14
msn.com - August 3 at 4:43 PM
msn.com logoEF Hutton Maintains Nemaura Medical (NMRD) Buy Recommendation
msn.com - July 17 at 8:09 PM
fool.com logoNemaura Medical (NASDAQ: NMRD)
fool.com - July 14 at 1:02 PM
finance.yahoo.com logoNemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023
finance.yahoo.com - July 14 at 9:37 AM
finance.yahoo.com logoNemaura Medical Scales-Up Pilot Expansion of proBEAT™; 56 Corporations in the U.S. Signed Up for Pilots in June 2023
finance.yahoo.com - June 27 at 1:48 PM
finance.yahoo.com logoNemaura Medical to Participate at the Collision Conference in Toronto June 26-29, 2023
finance.yahoo.com - June 22 at 9:14 AM
finance.yahoo.com logoNemaura Medical to Exhibit and Provide Live Product Demonstrations of Its Non-invasive Glucose Sensor at the 83rd Scientific Sessions of the American Diabetes Association June 23-26, 2023
finance.yahoo.com - June 15 at 8:48 AM
benzinga.com logoNemaura Medical Stock (NASDAQ:NMRD), Insider Trading Activity
benzinga.com - June 1 at 2:47 AM
finance.yahoo.com logoNemaura Medical to Participate in Fireside Chat Hosted by EF Hutton
finance.yahoo.com - March 21 at 9:21 AM
finance.yahoo.com logoNemaura Includes Insulin on List of Drugs Eligible for EU DuoPack License Agreement
finance.yahoo.com - March 15 at 8:29 AM
finance.yahoo.com logoNemaura Medical Announces Receipt of Notice from Nasdaq
finance.yahoo.com - March 9 at 5:55 PM
finanznachrichten.de logoNemaura Medical, Inc: Nemaura Medical Reports Fiscal Third Quarter 2023 Results and Provides Business Update
finanznachrichten.de - February 24 at 3:30 PM
finance.yahoo.com logoNemaura Medical, Inc. (NMRD) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - February 24 at 3:30 PM
finance.yahoo.com logoNemaura Medical Reports Fiscal Third Quarter 2023 Results and Provides Business Update
finance.yahoo.com - February 24 at 9:47 AM
finance.yahoo.com logoNemaura Medical to Participate in Fireside Chat at the MicroCap Rodeo Winter Wonderland Best Ideas 2023 Virtual Conference
finance.yahoo.com - February 16 at 9:36 AM
finance.yahoo.com logoNemaura Medical Announces Closing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement
finance.yahoo.com - January 31 at 2:35 PM
finance.yahoo.com logoNemaura Medical Announces Pricing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement
finance.yahoo.com - January 27 at 8:43 AM
marketwatch.com logoNemaura Medical Shares Rise 19% After New Purchase Order
marketwatch.com - January 26 at 1:12 PM
Get Nemaura Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter.

Analysts Predict Price Tag for Gold to TRIPLE (Ad)

Due to both domestic and global issues, the trajectory of this precious metal could skyrocket in the coming months… Which is why billionaires and Central Banks alike are scooping up gold at record rates!

Read Colonial Metals' new Precious Metals Investment Guide.

NMRD Media Mentions By Week

NMRD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NMRD
News Sentiment

0.00

0.61

Average
Medical
News Sentiment

NMRD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NMRD Articles
This Week

0

1

NMRD Articles
Average Week

Get Nemaura Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:NMRD) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners